Vicki L. Sato
Director · Allogene Therapeutics, Inc.
- 2024
- Jun 23, 2026
- 16
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vicki L. Sato files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SVF Endurance (Cayman) Ltd - $10.16M in VIR purchases and sales in the last 12 months
- Backer Marianne de - $947K in VIR purchases and sales in the last 12 months
- David D. Chang - $289K in ALLO purchases and sales in the last 12 months
- Nancy Thornberry - $262K in DNLI purchases and sales in the last 12 months
- Verneuil Vanina de - $218K in VIR purchases and sales in the last 12 months
- Alexander O. Schuth - $137K in DNLI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vicki L. Sato?
Vicki L. Sato is a corporate insider, tracked as Director of Allogene Therapeutics, Inc. (ALLO). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Vicki L. Sato last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 16 filings going back to 2024.
Has Vicki L. Sato been buying or selling stock?
Recorded transactions: 0 open-market purchases and 15 open-market sales ($2.04M) across all tracked filings.
